90 related articles for article (PubMed ID: 3842696)
1. Low molecular weight immunomodifiers produced by microorganisms.
Umezawa H; Ishizuka M
Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23 Suppl 1():S9-13. PubMed ID: 3842696
[TBL] [Abstract][Full Text] [Related]
2. Recent studies on antibiotics and small molecular immunomodulators with potential usefulness in treating lung cancer: Part II - Small molecular weight immunomodulators produced by microorganisms.
Umezawa H
Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):19-23. PubMed ID: 7056602
[TBL] [Abstract][Full Text] [Related]
3. Studies on low-molecular-weight immunomodifiers produced by microorganisms: results of ten years' effort.
Umezawa H
Rev Infect Dis; 1984; 6(3):412-20. PubMed ID: 6234644
[TBL] [Abstract][Full Text] [Related]
4. [Low molecular weight immunomodulators produced by microorganisms].
Ishizuka M
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2709-14. PubMed ID: 6508323
[TBL] [Abstract][Full Text] [Related]
5. Screening of small molecular microbial products modulating immune responses and bestatin.
Umezawa H
Recent Results Cancer Res; 1980; 75():115-25. PubMed ID: 7232823
[TBL] [Abstract][Full Text] [Related]
6. Low-molecular-weight immunomodifiers produced by micro-organisms.
Umezawa H
Biotechnol Genet Eng Rev; 1985; 3():255-73. PubMed ID: 2936359
[No Abstract] [Full Text] [Related]
7. [Low-molecular weight immunostimulants: cell membrane enzyme inhibitors].
Lin ZB; Shi JP
Sheng Li Ke Xue Jin Zhan; 1985 Apr; 16(2):115-20. PubMed ID: 3892667
[No Abstract] [Full Text] [Related]
8. [Secondary microbial metabolites with potentials for antineoplastic actions: antineoplastic antibiotics and immunopotentiators].
Umezawa H
Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1071-86. PubMed ID: 6191672
[TBL] [Abstract][Full Text] [Related]
9. In vivo actions of bestatin-related compounds in relation to their actions in vitro.
Aoyagi T; Wada T; Ohuchi S; Kawamura K; Fukatsu S; Umezawa H
Biochem Int; 1984 Nov; 9(5):643-50. PubMed ID: 6525200
[TBL] [Abstract][Full Text] [Related]
10. [Experimental and clinical studies of bestatin as an immunomodulator].
Miwa H; Oka T; Tsurumi T; Sakae Y; Orita K
Gan To Kagaku Ryoho; 1982 Jul; 9(6):1019-24. PubMed ID: 7184437
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of tumor cell invasion by ubenimex (bestatin) in vitro.
Saiki I; Murata J; Watanabe K; Fujii H; Abe F; Azuma I
Jpn J Cancer Res; 1989 Sep; 80(9):873-8. PubMed ID: 2513304
[TBL] [Abstract][Full Text] [Related]
12. Fundamental studies on bestatin: a small molecular microbial product enhancing immune response.
Umezawa H
Recent Results Cancer Res; 1981; 76():209-21. PubMed ID: 7232851
[No Abstract] [Full Text] [Related]
13. Similar effects of various low-molecular-weight enzyme inhibitors on enzyme networks in dystrophic mice.
Aoyagi T; Wada T; Ohuchi S; Kojima F; Nagai M; Harada S; Umezawa H
J Pharmacobiodyn; 1984 Sep; 7(9):681-7. PubMed ID: 6527211
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of ubenimex (bestatin) on the invasion of uterine cervical carcinoma cells and their production and activation of gelatinase A.
Ueda M; Ueki M; Fujii H; Yoshizawa K; Nakajima M
J Med; 1997; 28(3-4):175-90. PubMed ID: 9355022
[TBL] [Abstract][Full Text] [Related]
15. The relationships between enzyme inhibitors and function of mammalian cells.
Aoyagi T; Umezawa H
Acta Biol Med Ger; 1981; 40(10-11):1523-9. PubMed ID: 7044007
[TBL] [Abstract][Full Text] [Related]
16. [Phase I study of Bestatin: (I) A clinical study on determination of an optimal dose of Bestatin].
Saito K; Miyasato H; Tajima K; Ikeda S
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt):211-7. PubMed ID: 6881973
[TBL] [Abstract][Full Text] [Related]
17. Enkephalin degradation in the guinea-pig ileum: effect of aminopeptidase inhibitors, puromycin and bestatin.
Cohen ML; Geary LE; Wiley KS
J Pharmacol Exp Ther; 1983 Feb; 224(2):379-85. PubMed ID: 6822962
[TBL] [Abstract][Full Text] [Related]
18. Studies on the mechanisms of action of the immunomodulator Bestatin in various screening test systems.
Schorlemmer HU; Bosslet K; Dickneite G; Lüben G; Sedlacek HH
Behring Inst Mitt; 1984 May; (74):157-73. PubMed ID: 6383322
[TBL] [Abstract][Full Text] [Related]
19. Effect of forphenicinol, a small molecular immunomodifier, in combination with cyclophosphamide on growth of and immunity to syngeneic murine tumors.
Nitta K; Tanaka T; Takeuchi M
Cancer Treat Rep; 1985 Mar; 69(3):285-91. PubMed ID: 3978657
[TBL] [Abstract][Full Text] [Related]
20. Aminopeptidase inhibitor ubenimex (bestatin) inhibits the growth of human choriocarcinoma in nude mice through its direct cytostatic activity.
Inoi K; Goto S; Nomura S; Isobe K; Nawa A; Okamoto T; Tomoda Y
Anticancer Res; 1995; 15(5B):2081-7. PubMed ID: 8572606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
